NICE backs NHS use of Lilly’s Olumiant in eczema
Oral JAK inhibitor approved to treat moderate-to-severe atopic eczema in adults
Read More
Tag: eczema
Sanofi’s Dupixent approved for routine NHS use
Adults with moderate to severe atopic dermatitis are a step closer to being able to routinely access treatment with Sanofi’s Dupixent on the NHS, following a green light from cost regulators.
Read More
FDA clears Pfizer’s potential eczema blockbuster
Pfizer’s Eucrisa has been cleared by the US Food and Drug Administration as a treatment for mild to moderate atopic dermatitis in patients two years of age and older.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
